Advanced search
Publication Cover
Vascular Health and Risk Management Volume 16, 2020 - Issue
Submit an article Journal homepage
123
Views
4
CrossRef citations to date
0
Altmetric
Review

An Overview of the Treatment of Symptomatic Common Femoral Artery Lesions with a Focus on Endovascular Therapy

Nicolas W ShammasMidwest Cardiovascular Research Foundation, Davenport, IA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8279-0111
ORCID Icon,
Amanda Abi DoumetMidwest Cardiovascular Research Foundation, Davenport, IA, USA
,
Rusina KariaMidwest Cardiovascular Research Foundation, Davenport, IA, USA
&
Rommy KhalafallahMidwest Cardiovascular Research Foundation, Davenport, IA, USA
Pages 67-73 | Published online: 20 Feb 2020

References

  • Ballotta E, Gruppo M, Mazzalai F, Da Giau G. Common femoral artery endarterectomy for occlusive disease: an 8-year single-center prospective study. Surgery. 2010;147:268–274. doi:10.1016/j.surg.2009.08.004
  • Dufranc J, Palcau L, Heyndrickx M, et al. Technique and results of femoral bifurcation endarterectomy by eversion. J Vasc Surg. 2015;61:728–733. doi:10.1016/j.jvs.2014.09.025
  • Nguyen BN, Amdur RL, Abugideiri M, et al. Postoperative complications after common femoral endarterectomy. J Vasc Surg. 2015;61:1489–1494. doi:10.1016/j.jvs.2015.01.024
  • Wieker CM, Schönefeld E, Osada N, et al. Results of common femoral artery thromboendarterectomy evaluation of a traditional surgical management in the endovascular era. J Vasc Surg. 2016;64:995–1001. doi:10.1016/j.jvs.2016.04.036
  • Bonvini RF, Rastan A, Sixt S, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011;58:792–798. doi:10.1016/j.jacc.2011.01.070
  • Thiney PO, Millon A, Boudjelit T, Della Schiava N, Feugier P, Lermusiaux P. Angioplasty of the common femoral artery and its bifurcation. Ann Vasc Surg. 2015;29:960–967. doi:10.1016/j.avsg.2015.02.001
  • Azéma L, Davaine JM, Guyomarch B, et al. Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg. 2011;41:787–793. doi:10.1016/j.ejvs.2011.02.025
  • Nasr B, Kaladji A, Vent PA, et al. Long- term outcomes of common femoral artery stenting. Ann Vasc Surg. 2017;40:10–18. doi:10.1016/j.avsg.2016.07.088
  • Siracuse JJ, Van Orden K, Kalish JA, et al.; Vascular Quality Initiative. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative. J Vasc Surg. 2017;65:1039–1046. doi:10.1016/j.jvs.2016.10.078
  • Linni K, Ugurluoglu A, Hitzl W, Aspalter M, Hölzenbein T. Bioabsorbable stent implantation vs. common femoral artery endarterectomy: early results of a randomized trial. J Endovasc Ther. 2014;21:493–502. doi:10.1583/14-4699R.1
  • Gouëffic Y, Della Schiava N, Thaveau F, et al. Stenting or surgery for de novo common femoral artery stenosis. JACC Cardiovasc Interv. 2017;10:1344–1354. doi:10.1016/j.jcin.2017.03.046
  • Changal KH, Syed MA, Dar T, Mangi MA, Sheikh MA. Systematic review and proportional meta-analysis of endarterectomy and endovascular therapy with routine or selective stenting for common femoral artery atherosclerotic disease. J Interv Cardiol. 2019;2019:1593401. doi:10.1155/2019/1593401
  • Soga Y, Tomoi Y, Sato K, Iida O, Yokoi H. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease. Cardiovasc Interv Ther. 2013;28:250–257. doi:10.1007/s12928-013-0164-1
  • Dattilo PB, Tsai TT, Kevin Rogers R, Casserly IP. Acute and medium term outcomes of endovascular therapy of obstructive disease of diverse etiology of the common femoral artery. Catheter Cardiovasc Interv. 2013;81:1013–1022. doi:10.1002/ccd.v81.6
  • Guo J, Guo L, Tong Z, Gao X, Wang Z, Gu Y. Directional atherectomy is associated with better long term efficiency compared to angioplasty for common femoral artery occlusive disease in Rutherford 2 to 4 patients. Ann Vasc Surg. 2018;51:65–71. doi:10.1016/j.avsg.2017.12.004
  • Cantu D, Jawaid O, Kokkinidis D, et al. Outcomes of drug-coated balloon angioplasty vs conventional balloon angioplasty for endovascular treatment of common femoral artery atherosclerotic disease. Cardiovasc Revasc Med. 2019;S1553–S8389(19):30751. doi:10.1016/j.carrev.2019.11.008.
  • Stavroulakis K, Schwindt A, Torsello G, et al. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease. J Endovasc Ther. 2017;25:92–99. doi:10.1177/1526602817748319
  • Cioppa A, Stabile E, Salemme L, et al. Combined use of directional atherectomy and drug-coated balloon for the endovascular treatment of common femoral artery disease: immediate and one-year outcomes. EuroIntervention. 2017;12:1789–1794. doi:10.4244/EIJ-D-15-00187
  • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67. doi:10.1016/j.jvs.2006.12.037

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.